Search
for
Sort by
Research 91–120 of 102
- 5‐α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population‐based cohort study
- Serenoa repens induced erectile dysfunction: Underdiagnosis and phytovigilance
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
- Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis
- Differential association between cumulative dose of 5α-reductase inhibitors and mortality
- Intraoperative Iris Behavior during Phacoemulsification Maneuvers in Rabbits Treated with Selective α1-Blocker, 5α-Reductase Inhibitor, or Anxiolytic Medication
- Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques
- The First Visit: Consult and Workup Before Sperm Banking
- Saw palmetto and finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome
- Treatment response to conventional and novel therapies in chronic prostatitis
- Dihydrotestosterone and 5α-Reductase
- Urological Drug Price Stewardship: Potential Cost Savings Based on the Mark Cuban Cost Plus Drug Company Model
- Rapid and Sensitive LC–MS–MS Method for the Simultaneous Estimation of Alfuzosin and Dutasteride in Human Plasma
- Reversible visual loss caused by combination therapy of alfuzosin and finasteride in a patient with uveitic glaucoma
- Alfuzosin/finasteride
- Alfuzosin/finasteride
- Validated HPTLC method for the simultaneous determination of alfuzosin, terazosin, prazosin, doxazosin and finasteride in pharmaceutical formulations
- A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms.
- Risk factors for intraoperative floppy iris syndrome: a retrospective study
- Medikamentöse Therapie des benignen Prostatasyndroms
- Editorial Comment
- Is sulfonamide group of tamsulosin main factor in the pathophysiology of floppy iris syndrome?
- Medikamentöse Therapie des benignen Prostatasyndroms (BPS)
- Medikamentöse Therapie des benignen Prostatasyndroms mit α1-Rezeptorblockern Grundlagen und klinische Ergebnisse
- Medical Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia
- The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction
- Key Clinical Trials in BPH
- Floppy Iris Syndrome
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)